Mitochondrial fission and fusion are important for mitochondrial function, and dynamin 1-like protein (DNM1L) is a key regulator of mitochondrial fission. We investigated the effect of mitochondrial fission on mitochondrial function and inflammation in fibroblast-like synoviocytes (FLSs) during rheumatoid arthritis (RA). DNM1L expression was determined in synovial tissues (STs) from RA and non-RA patients. 
| INTRODUC TI ON
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease and is characterized by progressive destruction of multiple joints and synovial.
1 Despite significant therapeutic advances, RA remains a huge threat for human health due to the high rate of patient disability. During the pathogenic process of RA, fibroblast-like synoviocytes (FLSs) in the intimal lining can produce high levels of pro-inflammatory cytokines and contribute to cartilage destruction. 2 FLSs have been considered therapeutic targets for RA interventions. However, how FLSs contribute to the pathogenesis of RA has not been clarified.
Hypoxia can alter mitochondrial morphology and lead to mitochondrial dysfunctions, with reduced levels of adenosine triphosphate (ATP) production, excessive reactive oxygen species (ROS) production, increasing mitochondrial DNA mutations and oxidative damages, which in turn enhance inflammation in the joint, contributing to the pathogenesis of RA. [3] [4] [5] Mitochondria are the main inducer and target of ROS. 6 A previous study has shown that excessive ROS induces mitophagy, 7 and feedback can remove damaged mitochondria to reduce ROS accumulation. 8 ROS can activate the NF-κB signalling to produce pro-inflammatory cytokines, promoting synovial inflammation. 9 It is notable that a defect in the mitochondrial respiratory chain (MRC) complex IV, and increased autophagy (mediated by LC3 and Beclin 1) are associated with the development of RA. 10, 11 Inhibition of mitochondrial function can aggravate inflammatory responses in FLSs. 12 Inhibition of mitochondrial functions exacerbates inflammatory responses in the joint in vivo. 13 In addition, treatment with anti-tumour necrosis factor (TNF) α can suppress mitochondrial mutagenesis in inflammatory arthritis. 14 Mitochondrial membrane depolarization in peripheral blood lymphocytes has been reported in patients with RA. 15 Accordingly, protecting mitochondrial function may be an effective intervention for RA.
Mitochondrial dynamics (fusion and fission) are crucial for multiple mitochondrial functions, including respiratory capacity, apoptosis, mitochondrial DNA stability, response to cellular stress and autophagy. 16 Notably, dynamin 1-like protein (DNM1L, a GTPase) and mitochondrial fission protein 1 (FIS1) regulate mitochondrial fission, whereas mitofusin 1 (MFN1), MFN2 and OPA1 regulate mitochondrial fusion. 17 Previous studies have shown that increased mitochondrial fission can promote ROS production, leading to oxidative stress. [18] [19] [20] [21] [22] [23] Hence, targeting mitochondrial fission may represent a therapeutic strategy to inhibit oxidative stress-related diseases.
DNM1L is conservatively expressed in the cytoplasm of many types of cells and is crucial for mitochondrial fission. 24 Following its activation, DNM1L can be translocated into the mitochondrial outer membrane and bind to mitochondrial adaptor protein FIS1 to drive the process of mitochondrial fission. 24 Accumulated evidence has
shown that excessive expression of DNM1L is associated with development of neurodegenerative diseases, diabetes, tumours, kidney diseases, sepsis and cardiac diseases. 17, [25] [26] [27] [28] [29] [30] However, it is still unclear whether excessive expression of DNM1L-mediated mitochondrial fission is associated with the progression of RA.
In this study, DNM1L expression was examined in synovial tissues (STs) of RA and non-RA patients. 
| MATERIAL S AND ME THODS

| Reagents
The specific reagents used in this study included antibodies against The partial fresh STs were washed with PBS and cut into small pieces. Subsequently, the tissue pieces were digested with 4 mg/mL of collagenase I (Invitrogen) at 37°C for 2 hours and filtered through a cell strainer (70 µm), followed by centrifugation. The obtained cells were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 100 U/mL of penicillin and 100 µg/mL of streptomycin. The cells at passages of 3-6 were used as FLSs for experiments.
All patients signed the written informed consent agreements before participation. The experimental protocols were approved by the Ethics Committee of Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University.
| Immunohistochemistry (IHC)
Another part of STs was fixed in 10% formalin overnight and paraffin-embedded. The ST sections were deparaffinized, rehydrated and treated with 3% H 2 O 2 in methanol for 10 minutes, followed by antigen retrieval in a microwave. After being blocked with 5%
BSA (AR0004; Boster), the sections were probed with anti-DNM1L
(1:300) at 4°C overnight, and the bound antibodies were detected with horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibodies (1:1000, AS014; ABclonal), followed by visualization using diaminobenzidine. Images were obtained under a light microscope (Olympus).
| Transfection of siRNA
Fibroblast-like synoviocytes (1 × 10 5 cells/mL) were cultured in 6-well plates overnight and then transfected with 100 nmol/L DNM1L-specific or control siRNA using lipofectamine 3000 (Invitrogen), according to the manufacturer's instruction. Three days later, DNM1L
expression was determined by qRT-PCR and Western blot assays.
| Quantitative real-time polymerase chain reaction (qRT-PCR)
Fibroblast-like synoviocytes (1 × 10 5 cells/mL) were treated with vehicle control, 50 µmol/L mdivi-1 or siRNA for 72 hours. Total RNA was extracted from the different groups of cells or fresh STs using TRIzol Reagent (Invitrogen). After removing genomic DNA using the Genomic DNA Removal Kit (ABM), each RNA sample (2 µg) was reversely transcribed into cDNA. The relative levels of target mRNA transcripts were determined by qRT-PCR using the SYBR Green PCR Kit (ABM).
Specific primers (Table 1) were used with the Rotor-Gene Q RT-PCR instrument (Qiagen GmbH, Hilden, Germany). All mRNA levels are expressed relative to the control (GAPDH) using the 2 −ΔΔCt method. 
| Transmission electron microscopy (TEM) and confocal microscopy
The different groups of FLSs and STs were fixed in glutaraldehyde at 4°C for 2 hours and post-fixed in 1% citric acid-0.1 mol/L phosphate buffer (PB) for 2 hours, followed by embedded. The ultra-thin sections (70 nm) were stained with uranyl acetate and lead citrate.
Images were collected using TEM (Hitachi, HT7700). In addition, the The fluorescent signals from this stain were also examined under a confocal microscope to determine mitochondrial membrane potential. 
| Western blot analysis
| Cell viability and apoptosis assays
The cell viability was measured using the CCK-8 assay kit. Briefly, The absorbance at 450 nm was measured using a microplate reader.
The apoptosis of different groups of cells was determined by flow cytometry using the Annexin V-FITC apoptosis Detection Kit.
Briefly, FLSs (5 × 10 5 cells/tube) were stained with 5 µL Annexin V-FITC and 10 µL PI in the dark for 10 minutes at room temperature.
The percentages of apoptotic cells were determined by flow cytometry (Epics XL-MCL, Beckman). In addition, following transfection with DNM1L-specific miRNA or control scramble siRNA for 72 hours, cells viability and apoptosis were determined.
| Reactive oxygen species (ROS) detection
The contents of cellular ROS were determined using ROS fluores- 
| Immunofluorescence staining
The NF-κBp65 nuclear accumulation was examined by immunofluorescence. Briefly, FLSs (0.5 × 10 4 cells/well) were cultured in 24-well culture plates and treated with vehicle or the DNM1L inhibitor for 24 hours. The cells were fixed with 4% paraformaldehyde and blocked with confining liquid (containing Triton X-100 and 5% BSA).
After being washed, the cells were probed with anti-NF-κBp65 (1:50)
at 4°C overnight, stained with Cy3-conjugated secondary antibody
(1:500), and then, the nuclei were stained using DAPI. The fluorescent signals were observed in an inverted fluorescence microscope. 
| GTPase activity assay
| Clinical and histological assessment of arthritis
The mice were monitored for arthritis signs every other day posttreatment. The severity of arthritis was scored from 0 to 4. 35 The paw thickness of individual mice was measured using a Vernier caliper. On day 50, the mice were killed, and their knee joints, liver and renal tissues were collected and fixed in 10% formalin. The tissue sections (4 µm) were stained with haematoxylin and eosin (H&E) or toluidine blue. In addition, their STs were used for analysing the expression of cytokine mRNAs. The ROS contents in crystal synovial membrane sections were determined by DHE staining. 
| RE SULTS
| Enhanced mitochondrial fission in STs of RA patients is correlated with disease severity
To investigate the mitochondrial dynamics in STs during the pathogenic process of RA, the morphologic changes of mitochondria were investigated in STs from RA and non-RA patients and examined their FLSs by TEM. As shown in Figure 1A , mitochondrial length in the RA group was shorter than non-RA group. Similarly, the length of mitochondria in FLSs from patients with RA was also shorter than that of FLSs from non-RA patients. Furthermore, qRT-PCR analysis indicated more DNM1L mRNA transcripts in the STs from the RA patients than non-RA patients ( Figure 1B ). IHC and Western blot analysis exhibited that the levels of DNM1L expression in STs from patients with RA were remarkably up-regulated, compared with that in the non-RA patients ( Figure 1C,D) . Interestingly, the ratio of
DNM1L-to-MFN1 (determined by qRT-PCR) had significantly positive
F I G U R E 2 DNM1L deficiency alters mitochondria morphology and mitochondrial membrane potential in FLSs. (A, B)
FLSs from RA patients were transfected with control (siCtrl) or DNM1L-specific siRNA (siDNM1L) for 72 h, and the relative levels of DNM1L expression were determined by Western blot and qRT-PCR. C, Effect of mdivi-1 concentration on DNM1L GTPase activity. D, Representative confocal microscopy images of mitochondrial morphology in different groups of FLSs, with staining by MitoTracker Green and quantitation of these data. Scale bars: 20 µm. E, Representative confocal microscopy images of the effect of DNM1L deficiency on mitochondrial membrane depolarization (JC-1 fluorescence) and quantitation of these data. The ratio of red to green signal was determined for quantitative analysis. Scale bars: 100 µm. Data are representative images or expressed as the mean ± SD of each group from three separate experiments. *P < .05; **P < .01; ***P < .001
correlations with the serum anti-CCP level (r = .733, P = .016), DAS28 score (r = .089, P = .004), and ESR (r = .693, P = .026, Figure 1E ).
However, the DNM1L-to-MFN1 ratio had no significant correlations with RF level, hs-CRP level or disease duration (data not shown). In addition, there were no significant differences in the expression of MFN2, FIS1 and OPA1 mRNAs among RA and non-RA individuals F I G U R E 3 DNM1L deficiency in FLSs reduces their viability and production of pro-inflammatory cytokines, and increases apoptosis. A, Cell viability was determined using the CCK-8 assay. (B, C) Western blot and qRT-PCR analyses of COX-2 and IL-8 expression in FLSs (mdivi-1 concentration = 50 µmol/L). D, Representative flow cytometry data of apoptotic FLSs after staining with FITC-Annexin V and PI, and quantitation of these data. Data are representative flow cytometry charts, images or expressed as mean ± SD of each group from three separate experiments. *P < .05; **P < .01; ***P < .001; ***P < .0001
(data not shown). Hence, some markers of enhanced mitochondrial fission in the STs of RA patients correlated with disease severity.
| DNM1L deficiency alters mitochondria morphology and mitochondrial membrane potential in FLSs
DNM1L is crucial for mitochondrial fission. Next, we examined how Figure 2E) . Collectively, such data indicated that DNM1L deficiency altered mitochondrial morphology and induced mitochondrial membrane depolarization in FLSs. In addition, treatment with 50 µmol/L mdivi-1 or DNM1L silencing significantly increased the percentages of apoptotic FLSs ( Figure 3D ).
| DNM1L deficiency in FLSs reduces their viability and production of pro-inflammatory cytokines and increases apoptosis
Thus, DNM1L deficiency reduced the viability of FLSs and their production of pro-inflammatory cytokines by triggering apoptosis.
| DNM1L deficiency reduces ROS production and LC3B-related autophagy in FLSs
To investigate the impact of DNM1L deficiency on ROS produc- Figure 4B ). Moreover, treatment with mdivi-1 or DNM1L silencing significantly decreased the ratio of LC3B-II to LC3B-I and the IL-1β-increased ratios of LC3B-II to LC3B-I in FLSs ( Figure 4C ). The results suggest that ROS and LC3B-related autophagy may play a key role in DNM1L-mediated proliferation, inflammation and apoptosis in RA FLS.
| DNM1L deficiency attenuates the IL-1β-induced NF-κB activation in FLSs
To further explore the role of DNM1L in RA FLS inflammation, we examined the effect of DNM1L deficiency on the IL-1β-induced AKT and Figure 6F ). In addition, treatment with mdivi-1 also decreased ROS production in the STs of mice ( Figure 6H ). However, histological examination revealed that treatment with mdivi-1 did not change the morphology of the liver and kidney tissues in mice (Figure5G). Therefore, treatment with mdivi-1 to impaired DNM1L activity and ameliorated the severity of CIA in mice by modulating the pro-inflammatory and anti-inflammatory responses, but had no effect on non-target tissues (liver and kidney).
| D ISCUSS I ON
In the present study, we found that up-regulated DNM1L expression in STs from patients with RA was associated with the severity of RA. Such findings support the notion that up-regulated mitochondrial fission is associated with the development of different types of diseases, including inflammatory diseases. 4, 17, [25] [26] [27] [28] [29] [36] [37] [38] [39] [40] To the best of our knowledge, this was the first report on up-regulated DNM1L expression in
STs from patients with RA and the correlations suggest that DNM1L expression may be a new biomarker to evaluate the severity of RA.
DNM1L is crucial for mitochondrial fission. MFN1 knockout mice display fragmented mitochondria. 41 In this study, we found that up-regulated DNM1L expression was associated with decreased length of mitochondria in STs, consistent with previous observations. 4, 17, 42 Similarly, DNM1L silencing and treatment with mdivi-1 also increased the length of mitochondria in FSLs. Hence, up-regulated DNM1L expression reflected enhanced mitochondrial fission, which should promote mitochondrial membrane depolarization and in tune enhance ROS production. Actually, a previous study has shown that mitochondrial membrane depolarization in peripheral lymphocytes is positively correlated with serum CRP levels and DAS28 values in patients with RA. 15 DNM1L deficiency promoted mitochondrial membrane depolarization and decreased the levels of ROS and pro-inflammatory COX-2 and IL-8 in RA FLSs, similar to that in synoviocytes. 12 We also found that the ratio of DNM1L-to-MFN1 transcripts correlated with the level of serum anti-CCP antibodies, DAS28 and ESR values in patients with RA. Such data suggest that DNM1L-related mitochondrial fission may contribute to the pathogenesis of RA.
Mdivi-1 inhibits DNM1L GTPase activity and is a potent inhibitor of mitochondrial fission. Previous studies demonstrated that mdivi-1 can inhibit myocardial infarction, stroke, neurodegenerative diseases, and cancers. 22, 25, 26, 36, [43] [44] [45] [46] In the present study, we found that mdivi-1 inhibited DNM1L GTPase activity in a dose-dependent manner, consistent with previous studies. 43, 47 Furthermore, treatment with mdivi-1 significantly reduced the severity of CIA in mice by decreasing pro-inflammatory cytokine production, but increasing anti-inflammatory IL-10 production. These, together with its inhibition on ROS and pro-inflammatory COX-2 and IL-8 production in FLSs, suggest that inhibition of mitochondrial fission may modulate the balance of pro-inflammatory and anti-inflammatory responses in joint lesions. Given that mitochondria are crucial for nutritional metabolisms, it is possible that inhibition of mitochondrial fission may differentially modulate glucose and lipid metabolisms to affect pathogenic and regulatory T-cell responses during the pathogenic process of RA.
It is well known that mitochondrial dysfunction can induce excessive ROS production, which promotes autophagy 17 and exacerbates synovial inflammation by activating the NF-κB signalling to promote the expression of pro-inflammatory cytokines. 12, 48 Furthermore, mitochondrial dysfunction can activate PI3K/AKT signalling, which is crucial for inflammation in RA FLSs. 17, 49 In addition, the activated AKT can induce IKK phosphorylation and NF-κB, which is down-regulated by NFKBIA. 50, 51 In this study, we found that treatment with mdivi-1 or DNM1L silencing effectively decreased ROS production and LC3B-related autophagy in FLSs, extending the previous observation in osteoblasts. 42 Moreover, DNM1L deficiency also mitigated the IL-1β-induced AKT and IKK phosphorylation and NF-κBp65 nuclear translocation, but increased NFKBIA expression in RA FLS.
Therefore, anti-oxidants and inhibition of mitochondrial fission to attenuate the AKT/IKK/NF-κB signalling may be promising strategies for treatment of RA.
This study had limitations, including a small sample size and the lack of studies on how inhibition of mitochondrial fission alters mitochondrial DNA and glucose and lipid metabolisms that affect pathogenic and regulatory T-cell responses. Hence, future investigations in a bigger population are warranted to determine molecular mechanisms by which the mitochondrial dynamic factors regulate the pathogenesis of RA.
In conclusion, our results indicated that up-regulated DNM1L expression in STs was associated with the severity of RA.
Treatment with mdivi-1 or DNM1L silencing altered mitochondrial morphology, promoted mitochondrial membrane depolarization and apoptosis, and decreased cell viability, ROS, LC3B-related autophagy and pro-inflammatory cytokine production in FLSs.
The same treatment also mitigated the IL-1β-mediated LC3B- 
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